Patency as defined by absence of occlusion or >50% restenosis rate at the level the treated lesion as determined by duplex control. 1 year [clinicaltrials_resource:29342436813fb1b48532fb0109ae766d]
A Registry will be used.
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]
Patency as defined by absence of occlusion or >50% restenosis rate at the level the treated lesion as determined by duplex control. 1 year [clinicaltrials_resource:29342436813fb1b48532fb0109ae766d]
A Registry will be used.
Bio2RDF identifier
29342436813fb1b48532fb0109ae766d
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:29342436813fb1b48532fb0109ae766d
measure [clinicaltrials_vocabulary:measure]
Patency as defined by absence ...... determined by duplex control.
time frame [clinicaltrials_vocabulary:time-frame]
description
A Registry will be used.
identifier
clinicaltrials_resource:29342436813fb1b48532fb0109ae766d
title
Patency as defined by absence ...... ined by duplex control. 1 year
@en
type
label
Patency as defined by absence ...... 42436813fb1b48532fb0109ae766d]
@en